ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,122,000 | +218.8% | 99,921 | +116.0% | 0.62% | +846.2% |
Q1 2016 | $1,293,000 | -68.1% | 46,258 | -59.4% | 0.06% | -70.9% |
Q4 2015 | $4,058,000 | -85.2% | 113,838 | -86.8% | 0.22% | -74.3% |
Q4 2014 | $27,446,000 | +106.2% | 864,437 | +46.7% | 0.87% | +51.8% |
Q2 2014 | $13,311,000 | +18.1% | 589,264 | +27.2% | 0.57% | -9.7% |
Q1 2014 | $11,268,000 | -19.1% | 463,146 | -16.9% | 0.63% | -28.8% |
Q4 2013 | $13,920,000 | +18.8% | 557,013 | +30.6% | 0.89% | +16.5% |
Q3 2013 | $11,719,000 | -19.7% | 426,600 | -47.0% | 0.76% | -21.8% |
Q2 2013 | $14,597,000 | – | 804,255 | – | 0.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |